Immunohistochemical expression of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 in canine simple mammary gland adenocarcinomas

Canadian Veterinary Journal

Volumn 51, Issue 10, 2010, Pages 1109-1114

  Al Dissi, Ahmad N ^a   Haines, Deborah M ^a   Singh, Baljit ^a   Kidney, Beverly A ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

KI 67 ANTIGEN; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR;

ADENOCARCINOMA; ANIMAL; ANIMAL DISEASE; ARTICLE; DOG; DOG DISEASE; EXPERIMENTAL NEOPLASM; FEMALE; GENE EXPRESSION REGULATION; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); VASCULARIZATION;

ADENOCARCINOMA; ANIMALS; DOG DISEASES; DOGS; FEMALE; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MAMMARY NEOPLASMS, ANIMAL; NEOVASCULARIZATION, PATHOLOGIC; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 78649361797     PISSN: 00085286     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995;1:27-31.
2. Hicklin DJ, Ellis LM. Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. J Clin Oncol 2005;23: 1011-1027.
3. Ferrara N. Vascular endothelial growth factor. Trends Cardiovasc Med 1993;3:244-250.
4. de Vries C, Escobedo JA, Ueno H, Houck K, Ferrara N, Williams LT. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 1992;255:989-991.
5. Terman BI, Dougher-Vermazen M, Carrion ME, et al. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem Biophys Res Commun 1992;187:1579-1586.
6. Ferrara N. Role of vascular endothelial growth factor in regulation of physiological angiogenesis. Am J Physiol Cell Physiol 2001; 280: C1358-C1366.
7. Fong GH, Rossant J, Gertsenstein M, Breitman ML. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 1995;376:66-70.
8. Dong P, Sakata K, Miyajima Y, Chijiwa K, Mori K, Nakashima T. The predictive value of p53, Ki-67 and angiogenetic factors in primary hypopharyngeal carcinoma. Kurume Med J 2001;48:261-266.
9. Nakopoulou L, Stefanaki K, Panayotopoulou E, et al. Expression of the vascular endothelial growth factor receptor-2/Flk-1 in breast carcinomas: Correlation with proliferation. Hum Pathol 2002;33:863-870.
10. Kushlinskii NE, Orinovskii MB, Gurevich LE, et al. Expression of biomolecular markers (Ki-67, PCNA, Bcl-2, BAX, BcIX, VEGF) in breast tumors Bull Exp Biol Med 2004;137:182-185.
11. Erovic BM, Pelzmann M, Grasl MC, et al. Mcl-1, vascular endothelial growth factor-R2, and 14-3-3sigma expression might predict primary response against radiotherapy and chemotherapy in patients with locally advanced squamous cell carcinomas of the head and neck. Clin Cancer Res 2005:11:8632-8636.
12. Koide N, Nishio A, Kono T, et al. Histochemical study of vascular endothelial growth factor in squamous cell carcinoma of the esophagus. Hepatogastroenterology 1999;46:952-958.
13. Dias PP, Azevedo M, Gartner F. Case of malignant biphasic mesothelioma in a dog. Vet Rec 2001;149:680-681.
14. Du JR, Jiang Y, Zhang YM, Fu H. Vascular endothelial growth factor and microvascular density in esophageal and gastric carcinomas. World J Gastroenterol 2003;9:1604-1606.
15. Tse GM, Lui PC, Lee CS, et al. Stromal expression of vascular endothelial growth factor correlates with tumor grade and microvessel density in mammary phyllodes tumors: A multicenter study of 185 cases. Hum Pathol 2004;35:1053-1057.
16. Al-Dissi AN, Haines DM, Singh B, Kidney BA. Immunohistochemical expression of vascular endothelial growth factor and vascular endothelial growth factor receptor associated with tumor cell proliferation in canine cutaneous squamous cell carcinomas and trichoepitheliomas. Vet Pathol 2007;44:823-830.
17. Bosari S, Lee AK, DeLellis RA, Wiley BD, Heatley GJ, Silverman ML. Microvessel quantitation and prognosis in invasive breast carcinoma. Hum Pathol 1992;23:755-761.
18. Macchiarini P, Fontanini G, Hardin MJ, Squartini F, Angeletti CA. Relation of neovascularisation to metastasis of non-small-cell lung cancer. Lancet 1992;340:145-146.
19. Wakui S, Furusato M, Itoh T, et al. Tumour angiogenesis in prostatic carcinoma with and without bone marrow metastasis: A morphometric study. J Pathol 1992;168:257-262.
20. Sadarides TJ, Speziale NJ, Drab E, Szeluga DJ, Rubin DB. Tumor angiogenesis and rectal carcinoma. Dis Colon Rectum 1994;37: 921-926.
21. Olivarez D, Ulbright T, DeRiese W, et al. Neovascularization in clinical stage A testicular germ cell tumor: Prediction of metastatic disease. Cancer Res 1994;54:2800-2802.
22. Bartoletti R, Cai T, Nesi G, Sardi I, Rizzo M. Qualitative and quantitative analysis of angiogenetic factors in transitional cell bladder carcinoma: Relationship with clinical course at 10 years follow-up. Oncol Rep 2005;14:251-255.
23. Li VW, Folkerth RD, Watanabe H, et al. Microvessel count and cerebrospinal fluid basic fibroblast growth factor in children with brain tumours. Lancet 1994;344:82-86.
24. Vacca A, Ribatti D, Roncali L, et al. Bone marrow angiogenesis and progression in multiple myeloma. Br J Haematol 1994;87:503-508.
25. Brody RS, Goldschmidt MH, Roszel J. Canine mammary gland neoplasia. J Am Anim Hosp Assoc 1985;19:61-90.
26. Rutteman GR, Withrow SJ, MacEwen EG. Tumors of the mammary gland. In: Withrow SJ, MacEwen EG, eds. Small Animal Clinical Oncology. 3rd ed. Philadelphia: WB Saunders, 2000:450-467.
27. Misdorp W Tumors of the mammary gland. In: Meuten DJ, ed. Tumors in Domestic Animals. 4th ed. Ames, Iowa: Iowa State Univer Pr, 2003:575-606.
28. Restucci B, Papparella S, Maiolino P, De Vico G. Expression of vascular endothelial growth factor in canine mammary tumors. Vet Pathol 2002;39:488-493.
29. Maiolino P, De Vico G, Restucci B. Expression of vascular endothelial growth factor in basal cell tumours and in squamous cell carcinomas of canine skin. J Comp Pathol 2000;123:141-145.
30. Rawlings NG, Simko E, Bebchuk T, Caldwell SJ, Singh B. Localization of integrin alpha(v)beta3 and vascular endothelial growth factor receptor-2 (KDR/Flk-1) in cutaneous and oral melanomas of dog. Histol Histopathol 2003;18:819-826.
31. Maiolino P, Papparella S, Restucci B, De Vico G. Angiogenesis in squamous cell carcinomas of canine skin: An immunohistochemical and quantitative analysis. J Comp Pathol 2001;125:117-121.
32. Restucci B, De Vico G, Maiolino P. Evaluation of angiogenesis in canine mammary tumors by quantitative platelet endothelial cell adhesion molecule immunohistochemistry. Vet Pathol 2000;37:297-301.
33. Restucci B, Maiolino P, Paciello O, Mariano M, De Vico G, Papparella S. Evaluation of angiogenesis in canine seminomas by quantitative immunohistochemistry. J Comp Pathol 2003; 128:252-259.
34. Restucci B, Borzacchiello G, Maiolino P, Martano M, Paciello O, Papparella S. Expression of vascular endothelial growth factor receptor Flk-1 in canine mammary tumours. J Comp Pathol 2004;130:99-104.
35. Martin De Las MJ, Millan Y, Ruiz-Villamor E, Bautista MJ, Rollon E, Espinosa De Los MA. Apoptosis and mitosis in tumours of the skin and subcutaneous tissues of the dog. Res Vet Sci 1999;66:139-146.
36. Al-Dissi AN, Haines DM, Singh B, Kidney BA. Immunohistochemical expression of vascular endothelial growth factor and vascular endothelial growth factor receptor in canine cutaneous fibrosarcomas. J Comp Pathol 2009;141:229-236.
37. Haines DM, Chelack BJ. Technical considerations for developing enzyme immunohistochemical staining procedures on formalin-fixed paraffin-embedded tissues for diagnostic pathology. J Vet Diagn Invest 1991;3:101-112.
38. Hasan J, Byers R, Jayson GC. Intra-tumoural microvessel density in human solid tumours. Br J Cancer 2002;86:1566-1577.
39. Cohen J. Differences between correlation coefficients. In: Statistical Power Analysis for the Behavioral Sciences. 2nd ed. Mahwah, New Jersey: Lawrence Erlbaum, 1988:109-139.
40. Scase TJ, Edwards D, Miller J, et al. Canine mast cell tumors: Correlation of apoptosis and proliferation markers with prognosis. J Vet Intern Med 2006;20:151-158.
41. Zacchetti A, van Garderen E, Teske E, Nederbragt H, Dierendonck JH, Rutteman GR. Validation of the use of proliferation markers in canine neoplastic and non-neoplastic tissues: Comparison of KI-67 and proliferating cell nuclear antigen (PCNA) expression versus in vivo bromodeoxyuridine labelling by Immunohistochemistry. APMIS 2003; 111:430-438.
42. Phillips BS, Kass PH, Naydan DK, Winthrop MD, Griffey SM, Madewell BR. Apoptotic and proliferation indexes in canine lymphoma. J Vet Diagn Invest 2000;12:111-117.
43. Roels S, Tilmant K, Ducatelle R. PCNA and Ki67 proliferation markers as criteria for prediction of clinical behaviour of melanocytic tumours in cats and dogs. J Comp Pathol 1999;121:13-24.
44. Griffey SM, Kraegel SA, Madewell BR. Proliferation indices in spontaneous canine lung cancer: Proliferating cell nuclear antigen (PCNA), Ki-67 (MIB1) and mitotic counts. J Comp Pathol 1999;120:321-132.
45. Pena LL, Nieto AI, Perez-Alenza D, Cuesta P, Castano M. Immunohistochemical detection of Ki-67 and PCNA in canine mammary tumors: Relationship to clinical and pathologic variables. J Vet Diagn Invest 1998;10:237-246.
46. Weigand M, Hantel P, Kreienberg R, Waltenberger J. Autocrine vascular endothelial growth factor signalling in breast cancer. Evidence from cell lines and primary breast cancer cultures in vitro. Angiogenesis 2005; 8:197-204.
47. Bachelder RE, Crago A, Chung J, et al. Vascular endothelial growth factor is an autocrine survival factor for neuropilin-expressing breast carcinoma cells. Cancer Res 2001;61:5736-540.
48. Bachelder RE, Wendt MA, Mercurio AM. Vascular endothelial growth factor promotes breast carcinoma invasion in an autocrine manner by regulating the chemokine receptor CXCR4. Cancer Res 2002; 62:7203-7206.
49. Muller A, Homey B, Soto H, et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001;410:50-56.
50. Fox SB, Generali DG, Harris AL. Breast tumour angiogenesis Breast Cancer Res 2007;9:216.
51. Kato T, Steers G, Campo L, et al. Prognostic significance of microvessel density and other variables in Japanese and British patients with primary invasive breast cancer. Br J Cancer 2007;97:1277-1286.
52. Griffey SM, Verstraete FJ, Kraegel SA, Lucroy MD, Madewell BR. Computer-assisted image analysis of intratumoral vessel density in mammary tumors from dogs. Am J Vet Res 1998;59:1238-1242.
53. Jakab C, Halasz J, Kiss A, et al. Evaluation of microvessel density (MVD) in canine mammary tumours by quantitative immunohistochemistry of the claudin-5 molecule. Acta Vet Hung 2008;56:495-510.
54. Ferrer L, Fondevila D, Rabanal RM, Vilafranca M. Immunohistochemical detection of CD31 antigen in normal and neoplastic canine endothelial cells. J Comp Pathol 1995;112:319-326.
55. Pepper MS, Baetens D, Mandriota SJ, et al. Regulation of VEGF and VEGF receptor expression in the rodent mammary gland during pregnancy, lactation, and involution. Dev Dyn 2000;218:507-524.
56. Senger DR, Van De Water L. VEGF expression by epithelial and stromal cell compartments: Resolving a controversy. Am J Pathol 2000;157:1-3.